Zobrazeno 1 - 10
of 133
pro vyhledávání: '"Sven O. Skouby"'
Publikováno v:
Endocrine Connections, Vol 7, Iss 1, Pp 115-123 (2018)
Context: Women with polycystic ovary syndrome (PCOS) have an increased risk of cardiovascular disease (CVD), and biomarkers can be used to detect early subclinical CVD. Midregional-pro-adrenomedullin (MR-proADM), midregional-pro-atrial natriuretic
Externí odkaz:
https://doaj.org/article/a73dfea82d35446e94768d874e4168af
Publikováno v:
Endocrine Connections, Vol 6, Iss 2, Pp 89-99 (2017)
Polycystic ovary syndrome (PCOS) is associated with increased risk of venous thromboembolism (VTE) and cardiovascular disease (CVD) in later life. We aimed to study the effect of liraglutide intervention on markers of VTE and CVD risk, in PCOS. In a
Externí odkaz:
https://doaj.org/article/43046cc6d12d441982797eb87dc4ca43
Autor:
Liv C Poulsen, Agnieszka K Warzecha, Nathalie S Bülow, Leif Bungum, Nicholas S Macklon, Claus Yding Andersen, Sven O Skouby
Publikováno v:
Human Reproduction. 37:1557-1571
STUDY QUESTION What are the downstream endocrine and paracrine consequences of letrozole (LZ) cotreatment during ovarian stimulation and is follicle growth and recruitment affected? SUMMARY ANSWER Letrozole cotreatment induces marked changes in both
Autor:
Bart C J M Fauser, Jacques Donnez, Philippe Bouchard, David H Barlow, Francisco Vázquez, Pablo Arriagada, Sven O Skouby, Santiago Palacios, Janusz Tomaszewski, Boguslaw Lemieszczuk, Alistair R W William
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0173523 (2017)
To assess long term safety of extended repeated 3-month courses of ulipristal acetate (UPA) 10 mg/day, for up to 8 courses, with focus on endometrial and laboratory safety parameters.This long-term, multi-center, open-label cohort, follow up study co
Externí odkaz:
https://doaj.org/article/0a98d779bc45443b9be7be90e2356f64
Autor:
Juan Castillo-Fernandez, John R. B. Perry, Andrew Cho Chan, Gavin Kelsey, Eva Hoffmann, Nina la Cour Freiesleben, Sven O. Skouby, Alexia Cardona, Anne Zedeler, M.L. Grøndahl, Kristina W. Olsen, Mona Bungum
Publikováno v:
Fertility and Sterility. 115:732-741
To investigate whether epigenetic profiles of mural granulosa cells (MGC) and leukocytes from women with diminished ovarian reserve (DOR) differ from those of women with normal or high ovarian reserve.Prospectively collected material from a multicent
Autor:
Søren Brunak, Sven O. Skouby, Naba Al-Sari, Tibor V. Varga, Åsa Tornberg, Linda Ahonen, Cristina Legido-Quigley, Jose Alejandro Romero Herrera, Adnan Ali, Ismo Mattila
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Scientific Reports
Varga, T V, Ali, A, Herrera, J A R, Ahonen, L L, Mattila, I M, Al-Sari, N H, Legido-Quigley, C, Skouby, S, Brunak, S & Tornberg, Å B 2020, ' Lipidomic profiles, lipid trajectories and clinical biomarkers in female elite endurance athletes ', Scientific Reports, vol. 10, 2349 . https://doi.org/10.1038/s41598-020-59127-8
Scientific Reports
Varga, T V, Ali, A, Herrera, J A R, Ahonen, L L, Mattila, I M, Al-Sari, N H, Legido-Quigley, C, Skouby, S, Brunak, S & Tornberg, Å B 2020, ' Lipidomic profiles, lipid trajectories and clinical biomarkers in female elite endurance athletes ', Scientific Reports, vol. 10, 2349 . https://doi.org/10.1038/s41598-020-59127-8
We assessed whether blood lipid metabolites and their changes associate with various cardiometabolic, endocrine, bone- and energy-related comorbidities of Relative Energy Deficiency in Sport (RED-S) in female elite endurance athletes. Thirty-eight Sc
Autor:
N Sopa, H Udengaard, A K Warzecha, Sven O. Skouby, Anja Pinborg, M.L. Grøndahl, A.L. Englund Mikkelsen, N. Søderhamn Bülow, C. Yding Andersen, Nick S. Macklon, A. Nyboe Andersen, M. Dreyer Holt
Publikováno v:
Human Reproduction. 36
Study question Does reducing estradiol levels with letrozole co-treatment during ovarian stimulation with gonadotropins for IVF impact endocrinological and reproductive outcome markers in expected normal responders? Summary answer Letrozole co-treatm
Autor:
Agnieszka Katarzyna Warzecha, Sven O. Skouby, Nathalie Søderhamn Bülow, Marianne Dreyer Holt, Kathrine Birch Petersen, Nick S. Macklon, Anne Lis Englund Mikkelsen
Publikováno v:
Fertility and Sterility. 116:e109-e110
Publikováno v:
Hormone molecular biology and clinical investigationReferences. 43(2)
The need for luteal phase support in IVF/ICSI is well established. A large effort has been made in the attempt to identify the optimal type, start, route, dosage and duration of luteal phase support for IVF/ICSI and frozen embryo transfer. These ques